By decreasing levels of hFABP in the hearts of diabetic-treated animals, Anchomanes difformis reduces pro-inflammatory cytokines, increases anti-inflammatory markers, enhances antioxidant defense, and mitigates the progression of DCM [88]. Here, FABP3 is linked to familial dilated cardiomyopathy.